RUBFILA International Limited has submitted its newspaper publication of unaudited financial results for the quarter ended 31st December 2025 to stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. The company announced its Q3FY26 financial results with revenue of ₹12,161.10 lakhs, demonstrating steady performance across its business segments.

Regulatory Compliance and Publication

The company submitted the required documentation to both BSE and NSE on 16th February 2026, including copies of financial results published in Hindu Business Line (all editions) in English and Kerala Kaumudi (Palakkad Edition) in Malayalam on 15th February 2026. The submission was made by M Sudhesh, Assistant General Manager (Finance & Legal), ensuring compliance with regulatory requirements.

Standalone Financial Performance

The company's standalone operations showed mixed results for Q3FY26. Revenue from operations reached ₹12,161.10 lakhs, representing a 3.80% increase from ₹11,715.76 lakhs in Q3FY25. However, the quarter-on-quarter comparison showed a decline from ₹12,820.90 lakhs in Q2FY26.

For the nine-month period, the company achieved revenue from operations of ₹37,320.71 lakhs compared to ₹34,250.75 lakhs in the corresponding period of the previous year, marking an 8.96% growth. Net profit for the nine months stood at ₹1,805.51 lakhs versus ₹1,696.02 lakhs, showing a 6.46% increase.

Consolidated Results

The consolidated financial results, which include the wholly-owned subsidiary Premier Tissues India Limited, showed stronger performance. Consolidated revenue from operations for Q3FY26 was ₹14,673.44 lakhs compared to ₹13,796.57 lakhs in Q3FY25, representing a 6.36% growth.

Financial Position and Outlook

The company maintained a strong financial position with total assets of ₹32,909.50 lakhs as of 31st December 2025. Net worth increased to ₹28,159.27 lakhs from ₹27,439.12 lakhs. The company continues to operate as a zero-debt entity, with cash and cash equivalents of ₹3,085.21 lakhs.

The financial results were reviewed by the audit committee and approved by the Board of Directors on 13th February 2026. The statutory auditors issued an unmodified opinion on both standalone and consolidated results. The company addressed the impact of new Labour Codes notified in November 2025, stating no material incremental charges were recognized in the current period results.

Source:

Rubfila international has scheduled a board meeting for February 13, 2026, to approve its unaudited financial results for the third quarter of fiscal year 2026. The company made this announcement through a formal communication to stock exchanges dated February 3, 2026.

Board Meeting Details

The meeting agenda focuses on approving both standalone and consolidated unaudited financial results for the quarter ended December 31, 2025. This announcement was made in compliance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.

Trading Window Closure

In accordance with the company's Code of Conduct for Prevention of Insider Trading, Rubfila International has implemented a trading window closure for its shares. The trading restriction became effective from January 1, 2026, and will remain in place until 48 hours after the conclusion of the board meeting.

Stock Exchange Communication

The company has formally notified both major Indian stock exchanges about the upcoming board meeting. The communication was sent to the Bombay Stock Exchange, where the company trades under scrip code 500367, and the National Stock Exchange of India, where it is listed under the symbol RUBFILA. The notification was signed by N N Parameswaran, who serves as the company's CFO and Company Secretary.